BTI
JAZZ icon

Blue Trust Inc’s Jazz Pharmaceuticals JAZZ Stock Holding History

Blue Trust Inc’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$713K Sell
2,961
-42
-1% -$9.2K 0.01% 377
2026
Q1 		$568K Buy
3,003
+10
+0.3% +$1.75K 0.01% 449
2025
Q4 		$509K Sell
2,993
-268
-8% -$41.1K 0.01% 475
2025
Q3 		$430K Buy
3,261
+109
+3% +$13.1K ﹤0.01% 537
2025
Q2 		$334K Buy
3,152
+200
+7% +$21.7K ﹤0.01% 595
2025
Q1 		$366K Buy
2,952
+1,185
+67% +$155K ﹤0.01% 500
2024
Q4 		$218K Buy
1,767
+750
+74% +$88.4K ﹤0.01% 615
2024
Q3 		$109K Sell
1,017
-290
-22% -$31.8K ﹤0.01% 1179
2024
Q2 		$157K Buy
1,307
+257
+24% +$28.3K ﹤0.01% 800
2024
Q1 		$126K Buy
1,050
+1,036
+7,400% +$127K ﹤0.01% 646
2023
Q4 		$2K Buy
+14
New +$1.75K ﹤0.01% 2160
2023
Q3 		– Sell
-6
Closed -$1K – 2165
2023
Q2 		$1K Sell
6
-37
-86% -$4.98K ﹤0.01% 1865
2023
Q1 		$7K Buy
+43
New +$6.36K ﹤0.01% 1699
2022
Q4 		– Sell
-5
Closed -$1K – 2347
2022
Q3 		$1K Hold
5
– – ﹤0.01% 1939
2022
Q2 		$1K Buy
+5
New +$770 ﹤0.01% 1789

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Blue Trust Inc's JAZZ Position: Q2 2026 in Review

Blue Trust Inc reduced its Jazz Pharmaceuticals (JAZZ) stake by 1.4% in Q2 2026, selling an estimated $9.2K and leaving 2,961 shares worth $713K. The position accounts for 0.01% of the portfolio, ranked #377.

Blue Trust Inc first reported a position in JAZZ in Q2 2022 and has held it in 15 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Blue Trust Inc held 2,961 shares of Jazz Pharmaceuticals worth $713K as of Q2 2026.
  • Blue Trust Inc sold 42 Jazz Pharmaceuticals shares in Q2 2026, an estimated $9.2K.
  • Jazz Pharmaceuticals made up 0.01% of Blue Trust Inc's portfolio in Q2 2026, its #377 holding.
  • Blue Trust Inc first reported a position in Jazz Pharmaceuticals in Q2 2022 and has held it in 15 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.